Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

3

Usefulness of ΔMELD/month for Prediction of the Mortality in the First Episode of Variceal Bleeding Patients with Liver Cirrhosis: Comparison with CTP, MELD score and ΔCTP/month

Won Ki Bae, M.D., June Sung Lee, M.D., Nam Hoon Kim, M.D., Kyung Ah Kim, M.D., Young Soo Moon, M.D., Min Kyung Oh, Ph.D.

Clin Mol Hepatol. 2007;13(1):51-60. Published online January 1, 1970

View: 2880 Download: 28

Clinical Usefulness of ΔMELD to Predict the Survival of Patients with Liver Cirrhosis

Soo Hoon Eun, M.D., Yun Soo Kim, M.D. Jae Young Jang, M.D., Young Gook Cheon, M.D., Young Seok Kim, M.D., Young Deok Cho, M.D., Joon Sung Lee, M.D., Moon Sung Lee, M.D., Ju Hyun Kim, M.D. Chan Sup Shim, M.D., and Boo Sung Kim, M.D.

Clin Mol Hepatol. 2006;12(4):530-538. Published online January 1, 1970

View: 3174 Download: 20

1

Changes of MELD: Can Exceed Child-Pugh`s Authority?

June Sung Lee

Clin Mol Hepatol. 2006;12(4):475-478. Published online January 1, 1970

View: 2285 Download: 18

1 |

Viewed By 6938	MAFLD: How is it different from NAFLD?
Viewed By 6180	Epidemiology of metabolic dysfunction-associated steatotic liver disease
Viewed By 5291	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 5142	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4657	Role of noninvasive tests in the prognostication of metabolic dysfunction-associated steatotic liver disease

Cited By 298	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 266	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 170	MAFLD: How is it different from NAFLD?
Cited By 92	Non-alcoholic fatty liver disease: Definition and subtypes
Cited By 88	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

Search